SCHEMBL6662325

SCHEMBL6662325

Cn1cnc2c(C=Cc3ccc(F)cc3)ncnc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.44
ADORA2A P29274 1/20 0.44
YTHDC1 Q96MU7 1/20 0.42
NFE2L2 Q16236 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CDK1 P06493 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
PKM P14618 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6662321 1.00 ADORA1 (0.44) ADORA1ADORA2AYTHDC1NFE2L2NPC1
SCHEMBL6664891 0.85 CDK1 (0.48) ADORA1ADORA2AYTHDC1NPC1RAB9A
SCHEMBL6664888 0.85 CDK1 (0.48) ADORA1ADORA2AYTHDC1NPC1RAB9A
SCHEMBL6663756 0.73 ADORA1 (0.49) ADORA1ADORA2AYTHDC1KDM4EALDH1A1
SCHEMBL6660882 0.71 IP6K1 (0.46) NFE2L2NPC1RAB9AKDM4EMEN1
SCHEMBL6660879 0.71 IP6K1 (0.46) NFE2L2NPC1RAB9AKDM4EMEN1
SCHEMBL6659391 0.70 YTHDC1 (0.58) ADORA1ADORA2AYTHDC1NPC1RAB9A
SCHEMBL31061157 0.70 YTHDC1 (0.58) ADORA1ADORA2AYTHDC1NPC1RAB9A
SCHEMBL6663342 0.70 ADORA1 (0.45) ADORA1ADORA2AYTHDC1ALDH1A1MAPT
SCHEMBL6664688 0.67 SLC29A1 (0.57) NPSR1L3MBTL1CYP1A2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444982-A1 The use of purine derivatives as selective kinase inhibitors MERCKLE GMBH (DE) 2004-08-11 EP disclosed